The risks versus the benefits of pharmacological intervention in social anxiety disorder in children
Open Access
- 12 February 2025
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 25 (3) , 299-310
Abstract
Many children are affected by social anxiety disorder (SAD). Pharmacotherapy, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), may be indicated, but a clear understanding of the risks and benefits associated with these pharmacological treatments is needed. This expert review explores the risks and benefits of pharmacotherapy for treating SAD in children. Pharmacotherapy may be considered as a treatment when symptoms are complex or severe or when effective psychotherapy, such as cognitive behavioral therapy (CBT), is not accessible. We recommend that clinicians collaborate closely with parents, pediatricians, and psychiatrists in the treatment planning process, while monitoring the effects of pharmacotherapy. Future research should prioritize the personalization of treatments.Keywords
This publication has 91 references indexed in Scilit:
- Prenatal Antidepressant Exposure and Offspring Brain Morphologic TrajectoryJAMA Psychiatry, 2023
- Understanding Social Anxiety Disorder in Adolescents and Improving Treatment Outcomes: Applying the Cognitive Model of Clark and Wells (1995)Clinical Child and Family Psychology Review, 2018
- Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety DisordersJAMA Pediatrics, 2017
- Interpersonal Emotion Regulation Model of Mood and Anxiety DisordersCognitive Therapy and Research, 2014
- Cognitive-behavioral treatment of persistent functional somatic complaints and pediatric anxiety: an initial controlled trialDepression and Anxiety, 2011
- Advances in pharmacotherapy for pediatric anxiety disordersDepression and Anxiety, 2011
- Tenoten in the Therapy of Patients with Moderate Cognitive ImpairmentBulletin of Experimental Biology and Medicine, 2009
- Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant TreatmentJAMA, 2007
- The pharmacological management of childhood anxiety disorders: a reviewPsychopharmacology, 2007
- A Multicenter, Randomized, Double-blind, Placebo-Controlled Trial ofParoxetine in Children and Adolescents With Social Anxiety DisorderArchives of General Psychiatry, 2004